Wall Street analysts expect that Teligent Inc (NASDAQ:TLGT) will announce sales of $17.73 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for Teligent’s earnings. The lowest sales estimate is $17.65 million and the highest is $17.80 million. Teligent reported sales of $16.10 million during the same quarter last year, which indicates a positive year over year growth rate of 10.1%. The company is expected to announce its next earnings report on Thursday, March 21st.

According to Zacks, analysts expect that Teligent will report full year sales of $67.32 million for the current financial year, with estimates ranging from $67.24 million to $67.40 million. For the next financial year, analysts expect that the business will post sales of $85.10 million, with estimates ranging from $84.80 million to $85.40 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that that provide coverage for Teligent.

Teligent (NASDAQ:TLGT) last posted its quarterly earnings data on Tuesday, November 13th. The company reported ($0.01) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.01). The business had revenue of $18.29 million during the quarter, compared to analysts’ expectations of $19.80 million. Teligent had a negative return on equity of 44.64% and a negative net margin of 54.17%.

TLGT has been the subject of a number of recent analyst reports. ValuEngine upgraded Teligent from a “hold” rating to a “buy” rating in a research report on Friday, November 2nd. Canaccord Genuity dropped their price target on Teligent from $4.00 to $3.00 and set a “hold” rating for the company in a research report on Friday, November 16th.

Several institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. increased its position in shares of Teligent by 0.5% during the third quarter. BlackRock Inc. now owns 3,463,605 shares of the company’s stock worth $13,681,000 after purchasing an additional 16,198 shares in the last quarter. AMI Asset Management Corp increased its position in shares of Teligent by 1.9% during the fourth quarter. AMI Asset Management Corp now owns 2,714,292 shares of the company’s stock worth $3,719,000 after purchasing an additional 50,558 shares in the last quarter. Vanguard Group Inc increased its position in shares of Teligent by 0.7% during the third quarter. Vanguard Group Inc now owns 2,249,427 shares of the company’s stock worth $8,885,000 after purchasing an additional 15,800 shares in the last quarter. Sanders Morris Harris LLC increased its position in shares of Teligent by 6.1% during the fourth quarter. Sanders Morris Harris LLC now owns 1,545,032 shares of the company’s stock worth $2,117,000 after purchasing an additional 88,585 shares in the last quarter. Finally, Northpointe Capital LLC purchased a new stake in shares of Teligent during the third quarter worth approximately $2,948,000. Hedge funds and other institutional investors own 67.82% of the company’s stock.

Shares of Teligent stock traded down $0.07 on Friday, reaching $1.63. The company’s stock had a trading volume of 117,565 shares, compared to its average volume of 314,221. Teligent has a 52-week low of $1.13 and a 52-week high of $4.52. The company has a debt-to-equity ratio of 3.30, a quick ratio of 0.86 and a current ratio of 1.31.

Teligent Company Profile

Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, and markets generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms.

Featured Article: What are the Benefits of Index Funds?

Get a free copy of the Zacks research report on Teligent (TLGT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Teligent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent and related companies with MarketBeat.com's FREE daily email newsletter.